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Background: While substantial reductions in restenosis led to initial rapid uptake of drug-eluting stents (DES), concerns regarding stent 
thrombosis have subsequently led to more selective use. The impact of these changes on outcomes and the optimal rate of DES use, however, 
remain unknown.
Methods: We used data from the EVENT Registry to examine patterns of DES use among 10,144 unselected PCI pts treated at 55 US centers. 
One-year outcomes were compared between pts treated in 2004-6 (near-universal DES era, n=7587) and 2007 (selective DES era, n=2557) using 
hierarchical multivariable Cox regression models.
Results: DES use decreased from 92% in 2004-06 to 68% in 2007 (P<0.001). Few differences in pt characteristics were seen across time periods, 
although pts treated in 2007 were more likely to have ACS and received slightly shorter stents. There were no significant differences in rates of death 
or MI with more selective DES use, but there was an absolute 1% increase in target lesion revascularization (TLR: 2004-06: 4.1%, 2007: 5.1%, 
p=0.02) and a trend towards higher target vessel revascularization (Table). Comparing selective with liberal DES use, the NNT to avoid 1 TLR event 
was 24 (95% CI: 13-240).
Conclusion: Compared to near-universal DES implantation, more selective DES use was associated with a small but statistically significant 
increase in TLR. These data provide novel insights into the tradeoffs involved in DES utilization and can help to inform both clinical guidelines and 
health care policy. 
Table: Post discharge clinical outcomes over one year after PCI by time period
Liberal DES use
(2004-6, N=7587)
Selective
DES use
(2007, N=2557)
P-value
Multivariable risk estimates (2007 vs. 2004-6)
Hazard Ratio (95% CI) P-value
DES Use 92% 68% <0.001 - -
Death 2.9% 2.5% 0.30 1.0 (0.63-1.28) 0.77
Myocardial Infarction 
(MI)
2.0% 2.2% 0.53 1.13 (0.78-1.49) 0.48
Death or MI 4.6% 4.6% 0.99 1.04 (0.79-1.29) 0.75
Any TLR 4.1% 5.1% 0.03 1.36 (1.11-1.62) 0.02
Any TVR 5.6% 6.5% 0.09 1.23 (1.01-1.46) 0.07
Any Repeat 
revascularization
10.1% 10.6% 0.42 1.06 (0.89-1.24) 0.49
